Uric acide level in hypertensive patients

Objective & Hypothesis:OBJECTIVE: In hypertensive patients determined in emergency service, it's aimed to compare the relationship between uric acide levels and hypertension severity.

📊

Key Findings & Data:MATERIAL AND METHODS: The study group consisted of 150 cases, 100 of whom had hypertension and 50 of whom had normotensive.

💡

Conclusion & Impact:On the other hand, hyperuricemic patients should be followed-up for the risk of hypertension development.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Hipertansiyon · Araştırma teknikleri · Ürik asit

Abstract

OBJECTIVE: In hypertensive patients determined in emergency service, it's aimed to compare the relationship between uric acide levels and hypertension severity. MATERIAL AND METHODS: The study group consisted of 150 cases, 100 of whom had hypertension and 50 of whom had normotensive. Hypertensive patients were divided into two distinguished groups as hypertensive crisis group (n=50) and hypertension group (n=50). Hypertensive group consisted the patients who haven't had any treatment for the last 4 weeks or those who have just had diagnosis. Variance analysis and tukey test were used in the statistical analysis. RESULTS: When they were compared in terms of age and sex, the difference between the groups was found insignificant (p>0.05). The difference between hypertensive crisis group, and hypertension group, control group, when the groups were analysed according to their uric acide level, was found significant (p<0.05). The difference between hypertensive group and control group was found insignificant (p>0.05). CONCLUSION: There is quite significant relationship between uric acide levels and hypertension severity. Uric acide level should be monitored in such patients. On the other hand, hyperuricemic patients should be followed-up for the risk of hypertension development.

Özet

AMAÇ: Acil serviste tespit edilen hipertansif hastalarda, hipertansiyon şiddeti ile ürik asit düzeyleri arasındaki ilişkiyi karşılaştırmak amaçlandı. GEREÇ VE YÖNTEM: Çalışma grubu 100 hipertansif, 50 normotansif olmak üzere toplam 150 olgudan oluşmaktaydı. Hipertansif hastalar; hipertansif kriz grubu (n=50) ve hipertansiyon grubu (n=50) olmak üzere iki gruba ayrıldı. Hipertansif hastalar yeni tanı almış ya da son 4 haftadır tedavi almayan olgulardan oluştu. İstatistiksel analizde, varyans analizi ve tukey testi kullanıldı. BULGULAR: Gruplar yaş ve cinsiyet yönünden karşılaştırıldığıda aradaki fark önemsiz olarak bulunmuştur (p>0.05). Ürik asit yönünden gruplar incelendiğinde, hipertansif kriz grubu ile hipertansif grup ve kontrol grubu arasındaki farklılık anlamlı bulunurken (p 0.05), SONUÇ: Hipertansiyon şiddeti ile ürik asit düzeyleri arasında anlamlı bir ilişki vardır. Hipertansif hastaların takibinde ürik asit düzeyi göz önünde bulundurulmalı, hiperürisemili hastalar da hipertansiyon gelişimi açısından takip edilmelidir.

Keywords

Hipertansiyon Araştırma teknikleri Ürik asit Hypertension Investigative Techniques Uric Acid

🔖

Cite This Article

YILMAZ, K., ALAGÖZLÜ, H., AKTAŞ, C. (2002). Uric acide level in hypertensive patients. Medical Network Klinik Bilimler ve Doktor, Cilt: 8 - Sayı: 4, 437–440. https://ajindex.com/articles/278631

References (7)

Joint National Committee on Prevention. Detection, Evaluation, and treatment of High Blood Pressure. The Sixth Report of the Joint National committee on Prevention, Detection, Evaluation, and Treatment of High blood Pressure. Arch Intern Med. 1997; 157:2413-46. Hypertension in the Population at Large. Clinical Hypertension. Kaplan NM (ed) (Williams and Wilkins, Baltimore, 7th ed, 1998; 1-19. Türk Kardiyoloji Derneği Ulusal Hipertansiyon Tedavi ve Takip Kılavuzu. Türk Kardiyoloji Derneği Arşivi, Haziran 2000. Akpolat T. Hipertansiyon: Temel bilgiler. Hipertansiyon Güncel Sorunlar. Akpolat T, Yeşildağ O, (ed). Samsun 1998; 1-9. Bales A. Hypertensive crisis. Hypertension Symposium. Postgraduate Medicine, 1999; 105 (5). Hypertantensive Crises. Clinical Hypertension. Kaplan NM (ed) Williams and Wilkins, Baltimore, 7th ed, 1998; 265-81. Kültürsay H. Hipertansiyonun Komplikasyonları ve Tedavisi. Hipertansiyon, Önder R, Akıllı A, (ed) Nisan 1998; 210-22. Primary Hypertension: Natural History, Special Populations, and Evaluation. Clinical Hypertension, Kaplan NM (ed), Williams and Wilkins, Baltimore, 7th ed,1998; 101-33.
Frohlich, Edward D.Uric acid- a risk factor for coronary heart disease. Journal of the American Medical Association, 1993;.270:378-9.
Jing Frang, Michael H. Serum Uric Acid and Cardiovascular Mortality. Jama 2000; 283:2404-10.
Milionis HJ, Elisaf MS. Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: case histories. Curr Med Res Opin 2000; 16:164-70.
Lip GY, Beevers M, Beevers DG. Serum urate is associated with baseline renal dysfunction but not survival or deterioration in renal function im malignant phase hypertension. J Hypertens 2000; 18:97-101.
Franse LV, Pahor M, Di Bari M, Shorr RI, Wan JY, Somes GW, Applegate WB. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000; 18:1149-54.
Marilda M, Jeremy H, Yoon-Goo K, Ashley J, Duk-Hee K, Katherine L, Hui YL, Salah K, Richard JJ. Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism. Hypertension 2001; 38:1101. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japenese men: The Osaka Healty Survey. J Hypertens 2001; 19:1209-15. Makowiecka-Ciesla M. Accelerated and malignant hypertension- clinical observation. Pol Arch Med Wewn 1994; 91:214-22. Bic